mild and stable airway or parenchymal lung disease, or incidental disease detected on imaging, who have moderate-to-high disease activity Studies indicate that preexisting lung disease is a risk factor for methotrexate-related pneumonitis Heart failure Addition of a non-TNF inhibitor bDMARD or tsDMARD is conditionally recommended over addition of a TNF inhibitor for patients with New York Heart Association (NYHA) class III or IV heart failure and an inadequate response to csDMARDs Switching to